Loading clinical trials...
Loading clinical trials...
Multi-Disciplinary Discharge Counseling and MTM Services After Discharge for Heart Failure Patients
Readmission to a hospital shortly after discharge is a common and costly problem. In the United States patients with a diagnosis of heart failure currently experience an elevated 30 day readmission rate of approximately 20%. By providing patients with medication related counseling at discharge by a pharmacist, home medications at discharge, and seeing the patient again in a pharmacist-run Medication Therapy Management (MTM) clinic 7 days after discharge, the study anticipates achieving its primary goal of showing a reduction in the readmission rate. Secondary goals are: 1) to determine patients understanding of the medication they are taking, 2) to evaluate satisfaction with the comprehensive discharge counseling service, and 3) determine the number of interventions made and benefit of the MTM clinic.
The active arm of this study (medication related hospital discharge counseling by a pharmacist, home medications, and 7 day follow-up visit at a pharmacist run MTM clinic) is available to all subjects. To study the primary goal of reducing the 30 day readmission rate the data obtained from the active arm subjects will be compared to a match group of hospitalized patients that were previously discharged with a diagnosis of heart failure. The data for all secondary study goals will be obtained directly from the active arm subjects.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Providence Centralia Hospital
Centralia, Washington, United States
Providence St. Peter Hospital
Olympia, Washington, United States
Start Date
January 1, 2013
Primary Completion Date
May 1, 2013
Completion Date
May 1, 2013
Last Updated
May 22, 2013
1
ACTUAL participants
Discharge medication counseling from a pharmacist
OTHER
Home medication if needed
OTHER
Follow-up visit at Medication Therapy Management clinic
OTHER
Lead Sponsor
Providence Health & Services
NCT07484009
NCT07191730
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions